Brigatinib

brigatinib · Takeda Pharmaceuticals

Drug timelines are a Plus or Pro feature.

17 regulatory and trial events tracked for Brigatinib, covering 2017-06-21 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Brigatinib as Preferred First Therapy for Adults With Non-Small Cell Lung Cancer (NSCLC) ENTIRETY